Melanoma Reagents | abinScience

Главная > Рекомендуемая продукция > Oncology Research > Меланома

960 результатов продукта для "Меланома"

Опции+

Опции

Подтвердить

Типы продуктов

0 выбран

Assay Kit (419)

Proteins (75)

Biosimilars (1)

Research Biosimilar (157)

Antibodies (298)

Stable Cell Lines (1)
Система экспрессии

0 выбран

E. coli (35)

Mammalian Cells (186)

HEK293T (1)
Цель

0 выбран

CD175/Tn (10)

S100A6 (1)

Omalizumab (2)

HLA-A2-peptide (KTWGQYWQV) Complex (2)

Favezelimab (1)

CD86/B7-2 (26)

CD152/CTLA4 & CD274/PD-L1 (1)

Zampilimab (1)

NRAS (2)

TYR/Tyrosinase (2)

Trastuzumab (2)

Nirsevimab (1)

CD47/MER6 & PDCD1 / PD-1 / CD279 (1)

Obinutuzumab (2)

Cetuximab (3)

Ifabotuzumab (1)

CD366/HAVCR2/TIM-3 (4)

Spike glycoprotein E2 (2)

Simlukafusp Alfa (1)

LAG3 & PD-1 (1)

Daclizumab (1)

Enfortumab (1)

Emibetuzumab (1)

RBD (Delta) (3)

FLT1/VEGFR1 & CD274/PD-L1 (1)

RBD (Omicron/KP.2) (1)

Tibulizumab (1)

Ziltivekimab (1)

VASH2/Vasohibin-2 (1)

Carlumab (1)

RBD (Alpha) (1)

N/Nucleoprotein (1)

Tigatuzumab (1)

Glembatumumab (1)

Lenzilumab (1)

Semorinemab (1)

Talacotuzumab (1)

S100A5 (4)

Tremelimumab (1)

gG/US4 (2)

T-cell surface antigen T3/Leu-4 epsilon chain (1)

Pasotuxizumab (1)

TIGIT & CD274/PD-L1 (1)

Cixutumumab (1)

H3L (3)

TAU pT217 (1)

Andecaliximab (1)

Alirocumab (1)

Cinpanemab (1)

CD274/PD-L1 & CD28 (1)

Anifrolumab (1)

S100a15a (1)

CD152/CTLA4 & CD134/OX40 (1)

Rituximab (1)

CD274/PD-L1 & CD137/TNFRSF9 (1)

S100A12 (1)

S100A14 (1)

CD274/PD-L1 (81)

Depatuxizumab (1)

Retatrutide (1)

Zanidatamab (1)

Palivizumab (3)

KITLG/SCF (1)

Afutuzumab (1)

sCD14 (1)

CD366/TIM-3 (34)

Spike glycoprotein E1 (2)

Spike glycoprotein (10)

Crizanlizumab (1)

CD340/ERBB2 (1)

Codrituzumab (1)

Tanezumab (1)

Vunakizumab (1)

Tosatoxumab (1)

SOX10 (3)

RBD (Beta) (1)

Meplazumab (1)

Balstilimab (1)

Namilumab (1)

Dilpacimab (1)

Tilavonemab (1)

Natalizumab (2)

S100A8 (3)

Vibecotamab (1)

Zalifrelimab (1)

gB/Envelope glycoprotein B (1)

T-cell surface glycoprotein CD3 epsilon chain (1)

Rosopatamab (2)

Infliximab (2)

Frovocimab (1)

Dalotuzumab (1)

E8L (5)

S100A2 (1)

CD223/LAG3 & CD279/PD-1 (4)

Abatacept (1)

S100A13 (1)

S100A4 (3)

CD274/PD-L1 & CD152/CTLA4 (1)

Indatuximab (1)

S100B (9)

CD223/LAG3 (41)

CD279/PD-1 & CD274/PD-L1 (1)

CD137/4-1BB & CD274/PD-L1 & ROR1 & CD3 (1)

S100A1 (2)

Vofatamab (1)

Ustekinumab (3)

CD79B (2)

Losatuxizumab (1)

Afasevikumab (1)

β-D-Glucan (1)

Suptavumab (1)

B7-H1 / PD-L1 / CD274 & CD3E (1)

Epcoritamab (1)

F/Fusion glycoprotein F0 (5)

Letolizumab (1)

dsRNA (1)

Ibalizumab (1)

Ianalumab (1)

Tocilizumab (3)

Spike Protein (Trimer) (2)

Dupilumab (3)

Inclacumab (1)

IL1RL1/ST2 (1)

VSIR/VISTA & CD274/PD-L1 (1)

Cergutuzumab (1)

cGMP (1)

Lorvotuzumab (1)

RBD (Gamma) (1)

MITF (1)

Cetrelimab (1)

DCT (2)

Otilimab (1)

Navicixizumab (1)

VEGFA & B7-H1 / PD-L1 / CD274 (1)

Zagotenemab (1)

gE/Envelope glycoprotein E (1)

Tarextumab (1)

Lodelcizumab (1)

PD-L1 & VEGF (1)

Figitumumab (1)

A35R (5)

Farletuzumab (1)

p-Tyr (1)

Icrucumab (1)

CD152/CTLA4 (86)

CD274/PD-L1 & TGFBR2 (1)

CD279/PD-1 & CD152/CTLA4 (4)

CD274/PD-L1 & CD3E (1)

A29L (6)

Mirvetuximab (1)

B6R/SL-159 (1)

CD274/PD-L1/B7-H1 (5)

Necitumumab (1)

Bimekizumab (1)

Zenocutuzumab (1)

Glofitamab (1)

Guselkumab (3)

ATP7B (1)

Benufutamab (1)

Amatuximab (1)

Tregalizumab (1)

PD-L1 & TGF-Beta (1)

NP/Nucleocapsid (5)

dsDNA (1)

Astegolimab (1)

Adalimumab (3)

Tiragolumab (2)

Labetuzumab (1)

Obiltoxaximab (1)

BSA (1)

RBD (E484K) (1)

Alacizumab (1)

Faricimab (1)

Nivolumab (3)

Atezolizumab (3)

Sotrovimab (1)

MLANA (4)

Edrecolomab (1)

gD/Envelope glycoprotein D (1)

Urelumab (1)

Canakinumab (1)

LAG-3 & PD-1 (1)

Ganitumab (1)

Oxelumab (1)

TRP-1 & CD3e (1)

S100P (1)

CD223/LAG3 & CD152/CTLA4 (1)

S100A10 (4)

Lintuzumab (1)

CD274/PD-L1 & CD47/MER6 (1)

CD274/PD-L1 & SLT-Ia (1)

CD80/B7-1 (20)

Tezepelumab (1)

Teprotumumab (1)

IL6 (1)

Bevacizumab (3)

SARS-CoV-2 Neutralization Antibody (3)

Ivuxolimab (1)

PDL1 & VEGF (1)

Panitumumab (3)

Ixekizumab (1)

Siltuximab (3)

Suvizumab (1)

CD47/MER6 & PDCD1 / PD-1 & CD137/4-1BB/TNFRSF9 (1)

Ibritumomab (1)

RBD (Omicron/BA.4/BA.5) (1)

CD278/ICOS (1)

Itolizumab (1)

TPP15 (1)

Anetumab (1)

Zanolimumab (1)

Blosozumab (1)

Lacnotuzumab (1)

Iscalimab (1)

Olaratumab (1)

Glycoprotein (5)

PMEL17/ME20M (9)

Protein A (1)

Tisotumab (1)

RBD (Kappa) (1)

Ramucirumab (1)

Nesvacumab (1)

Pembrolizumab (3)

mitF/aspF1 (1)

Milatuzumab (1)

Avelumab (3)

Befovacimab (1)

Casirivimab (1)

Bimagrumab (1)

gC/Envelope glycoprotein C (1)

Utomilumab (1)

Gevokizumab (1)

CD47/MER6 & CD274/PD-L1 (2)

S100A16 (1)

HLA-A2-peptide (TDQVPFSV) Complex (1)

Ieramilimab (1)

CD274/PD-L1 & VEGFA (1)

TYRP1 (3)

CD19 & PD-L1 & CD3E & CD137 (1)

S100A9 (4)

Asp f 1/mitF (1)

CD274/PD-L1 & CD134/OX40 (1)

CD274/PD-L1 & CD28 & CD152/CTLA4 (1)

Magrolimab (1)

CD20/MS4A1 (3)

Etanercept (3)

Brolucizumab (1)

RBD (Omicron/BA.5) (3)

Pogalizumab (1)

Serclutamab (1)

Remtolumab (1)

Clazakizumab (1)

Mosunetuzumab (1)

TPP17 (1)

Conatumumab (1)

Romosozumab (1)

TYR (1)

Romiplostim (2)

Tovetumab (1)

M/Matrix protein (2)

CD3E (1)

Belantamab (1)

PD-L1 / VEGF-A (1)

Certolizumab (2)

Enoblituzumab (1)

Cabiralizumab (1)

Gremubamab (1)

Human β Amyloid (1-42) (1)

RBD (Delta Plus) (1)

Spike glycoprotein (RBD) (1)

Vanucizumab (1)

Sintilimab (1)

Glycoprotein G (2)

Durvalumab (3)

CD80&IL2 (1)

Concizumab (1)

Imdevimab (1)

CD117/KIT (24)

Rolinsatamab (1)

gC/UL44 (1)

Sarilumab (2)

CD152/CTLA4 & CD279/PD-1 (1)

HLA-A2-peptide (ITDQVPFSV) Complex (4)

EGFR & CD3E & PD-L1 & 4-1BB (1)

CD366/TIM-3 & CD274/PD-L1 (1)

TRP-1 & CD47/MER6 (1)

CD274/PD-L1 & CD279/PD-1 (1)

Oleclumab (1)

IDO1 (2)

CD366/TIM-3 & CD279/PD-1 (2)

Daratumumab (3)

gD/US6 (1)

Basiliximab (1)

Elezanumab (1)

Apamistamab (1)

Ranibizumab (3)

NP/Nucleoprotein (3)

Tavolimab (1)

Secukinumab (2)

Imlifidase (5)

Olokizumab (1)

Foravirumab (1)

CD47/MER6 & CD274/PD-L1/B7-H1 (2)

Ocaratuzumab (1)

Elotuzumab (1)

Cusatuzumab (1)

TPP47 (1)

Drozitumab (1)

Ontamalimab (1)

Eldelumab (1)

Sacituzumab (1)

Eculizumab (3)

Varlilumab (1)

Tirzepatide (2)

gp100 peptide-HLA Complex (1)

Teclistamab (1)

Mirzotamab (1)

CD223 (1)

Emactuzumab (1)

M1R (5)

Human β Amyloid (1-40) (1)

Imalumab (1)

Semaglutide (2)

Ascrinvacumab (1)

TFF3 (1)

Tislelizumab (1)

Disitamab (1)

Pacmilimab (1)

TDP2 (1)

Marstacimab (1)

HLA-A2-peptide (YLEPGPVT) Complex (4)

Calprotectin (S100A8/9) (3)

BRAF/B-Raf (5)

Mavezelimab (1)

CD137/4-1BB & CD274/PD-L1 (3)

TRP-1 & CD134/OX40 (1)

CD274/PD-L1 & TGFBR2/TGFR-2 (1)

CD80/B7-1 & CD86/B7-2 (2)

S100A11 (2)

CD137/4-1BB/TNFRSF9& CD274/PD-L1/B7-H1 (1)

Denosumab (3)

US8/gE (1)

Sibrotuzumab (1)

Fluorescein & CD274/PD-L1 (1)

Camidanlumab (1)

Mazdutide (2)

RBD (6)

Varisacumab (1)

RBD (Omicron/JN.1) (1)

Lirilumab (1)

CTLA4 & PD1 (2)

Tesidolumab (1)

Sirukumab (1)

Rafivirumab (1)

cAMP (1)

RBD (WT) (1)

Vorsetuzumab (1)

G/Major surface glycoprotein G (1)

Lexatumumab (1)

Mirikizumab (2)

PDL1 (6)

Aflibercept (1)

Ipilimumab (2)

GP/Envelope glycoprotein (4)

T3E (1)

Golimumab (3)

Omburtamab (1)

TAU pT181 (1)

Evolocumab (1)

EPO/Erythropoietin (1)

Lupartumab (1)

Toripalimab (1)

Exenatide acetate (2)

Pertuzumab (3)
Виды

0 выбран

Canis lupus familiaris (Dog) (8)

Homo sapiens (Human) (7)

Dog (3)

Human (178)

Felis catus (Cat) (9)

Cat (1)

Mouse (27)

Canis lupus familiaris (1)

Rat (1)

Neosartorya fumigata (1)

Tupaia chinensis (12)

Mus musculus (Mouse) (7)
Применения

0 выбран

GICA (2)

IHC (84)

in vivo (2)

in vivo intra-tumoral regulatory T cell depletion (2)

in vivo blockade (2)

Neut (1)

FCM (152)

FuncS (18)

WB (165)

Inhib (1)

IFA (4)

in vivo PD-L1 blockade (3)

SPR (4)

Bioactivity: FACS (153)

IP (2)

in vitro PD-L1 blockade (3)

SDS-PAGE (75)

Bioactivity: FACS (1)

Functional assay (158)

IHC-F (3)

FACS (5)

Иммуноген (75)

Research in vivo (158)

IF (8)

Functional assay (6)

Bioactivity testing in progress (31)

Research in vivo (4)

Neutralization (2)

Blocking (2)

in vivo CTLA-4 neutralization (2)

ELISA (844)
Реактивность

0 выбран

Kryptolebias marmoratus (1)

Avian retrovirus IC10 (1)

Chicken (4)

Limanda limanda (1)

Avian rous-associated virus type 1 (1)

Carassius auratus (1)

Tupaia chinensis (4)

Pig (6)

Mesocricetus auratus (1)

Bos taurus (8)

Coturnix japonica (1)

Cavia porcellus (1)

Dog (13)

Human (198)

Mouse (77)

Cynomolgus monkey (1)

Cyprinus carpio (1)

Callithrix jacchus (1)

Monodelphis domestica (1)

Oryctolagus cuniculus (4)

Pongo abelii (2)

B7-H1 / PD-L1 / CD274 (1)

Rhesus macaque (1)

Mus musculus (Mouse) (1)

Danio rerio (1)

Capra hircus (1)

Oryzias latipes (1)

Drosophila grimshawi (1)

Broad-Spectrum (1)

Xenopus laevis (1)

Macaca mulatta (1)

Bovine (1)

Rat (16)

Drosophila willistoni (1)

Neosartorya fumigata (1)

Homo sapiens (Human) (4)

Monkey (5)

Kirsten murine sarcoma virus (1)

Cat (1)
Хозяинский вид

0 выбран

Alpaca (6)

HEK293T (1)

Human (157)

Dog (2)

Mouse (164)

Armenian Hamster (5)

Rabbit (61)

Chimeric (5)

Rat (14)

Humanized (34)
Клоональность

0 выбран

Monoclonal (398)

Polyclonal (53)
Конъюгат

0 выбран

FITC (28)

APC (28)

PerCP (28)

Unconjugated (301)

PE (28)